XI’AN, CHINA -- (MARKET WIRE) -- April 17, 2007 -- Skystar Bio-Pharmaceutical Co., Ltd. (OTCBB: SKBI) (“Skystar”), a leading bio-pharmaceutical company in the People’s Republic of China (“PRC”), today announced that it has retained CCG Elite to design and execute its investor relations campaign.
